CCL2 and prostate cancer: Loberg et al. [131] revealed the high secretion of CCL2 by human bone marrow endothelial (HBME) cells and their ability to chemoattract as well as induce metastasis of prostate cancer cells, via an AKT-dependent signaling mechanism, into the bone microenvironment.